Sleeve Gastrectomy Carries a Higher Early Incidence of Rheumatoid Arthritis and Spondyloarthritis
Among adults treated surgically for morbid obesity, sleeve gastrectomy was associated with a higher early incidence of incident rheumatoid arthritis and spondyloarthritis than gastric bypass in a large French nationwide cohort. The signal emerged within the first six years after surgery, a window in which inflammatory disease may be unmasked by rapid weight loss, altered gut–immune signaling, or procedure-specific differences in metabolic remodeling.
The study drew on the French National Health Insurance Database and included 46,137 adults aged 18 to 65 years with morbid obesity, defined as BMI of at least 40 kg/m2, who underwent primary bariatric surgery between 2012 and 2016. Patients with prior immune-mediated inflammatory disorders, prior disease-modifying antirheumatic drug use, or earlier rheumatology consultations were excluded, leaving a cohort designed to capture new-onset rheumatic disease after surgery rather than pre-existing illness. Follow-up extended for as long as 10 years, and investigators used competing-risk methods to account for death while comparing gastric bypass, sleeve gastrectomy, and adjustable gastric banding.
The incidence data were unambiguous. Across 418,759 person-years of follow-up, 244 first diagnoses of rheumatoid arthritis or spondyloarthritis were recorded, for an overall incidence rate of 0.58 per 1,000 person-years. Gastric bypass had the lowest incidence rate at 0.43 per 1,000 person-years, adjustable gastric banding sat in the middle at 0.51 per 1,000 person-years, and sleeve gastrectomy was highest at 0.67 per 1,000 person-years.
The early divergence was concentrated in the comparison between sleeve gastrectomy and gastric bypass. During the first six years after surgery, sleeve gastrectomy was linked to a significantly higher risk of incident rheumatoid arthritis or spondyloarthritis than gastric bypass, with a subdistribution hazard ratio of 2.76 and a 95% confidence interval of 1.67 to 4.55. The p value was below 0.001. Adjustable gastric banding did not differ significantly from gastric bypass in that same early period, with a subdistribution hazard ratio of 1.53 and a 95% confidence interval of 0.67 to 3.52.
After six years, the groups converged statistically and no between-group differences remained detectable. That temporal pattern matters clinically because it suggests the excess risk is front-loaded rather than steadily accumulating across the full decade of observation. For rheumatologists and bariatric teams, the first years after surgery may be the period when inflammatory symptoms deserve the closest attention.
Why Procedure Choice May Matter for Immune-Mediated Arthritis
A biologic explanation is plausible even if the study design cannot prove causality. Gastric bypass and sleeve gastrectomy both induce weight loss, but they do so through different anatomical and hormonal pathways. Gastric bypass alters nutrient flow through the small bowel and reshapes enteroendocrine signaling more extensively, while sleeve gastrectomy primarily restricts gastric volume and changes gastric and appetite-related hormones. Those differences could translate into distinct downstream effects on systemic inflammation, adipokine balance, microbiome composition, and mucosal immune activation.
Obesity itself is a pro-inflammatory state, and weight reduction should, in theory, lower the burden of inflammatory arthritis. Yet the postoperative period is not biologically uniform. Rapid shifts in caloric intake, bile acid metabolism, and intestinal permeability may briefly destabilize immune homeostasis before longer-term metabolic benefits emerge. In a patient who is already genetically susceptible to autoimmune disease, that transitional phase could be enough to tip the balance toward clinical arthritis.
The procedure signal was also specific. Adjustable gastric banding did not show the same statistically significant excess risk relative to gastric bypass during the first six years, despite being another bariatric option. That pattern suggests the association is not explained simply by having undergone weight-loss surgery. Instead, the type of operation appears to matter.
The study’s competing-risk approach strengthens the analysis by acknowledging that some patients die before they can develop a rheumatic diagnosis, which would otherwise distort incidence estimates in a long follow-up cohort. Even so, the work remains observational. Residual confounding may persist despite adjustment for age, sex, obesity class, and Charlson Comorbidity Index, and claims-based diagnoses cannot fully substitute for chart-confirmed clinical classification.
What Clinicians Should Watch for After Bariatric Surgery
The bedside consequence is straightforward: new joint pain, prolonged morning stiffness, inflammatory back pain, enthesitis, or swollen peripheral joints after sleeve gastrectomy should not be dismissed as routine postoperative aches or deconditioning. A low threshold for rheumatology referral may be appropriate when symptoms develop in the early years after surgery, especially in patients with other features compatible with rheumatoid arthritis or spondyloarthritis.
Preoperative counseling may also need a more nuanced frame. Bariatric surgery remains an effective intervention for severe obesity, but the choice of operation can carry different long-term tradeoffs. This dataset does not suggest abandoning sleeve gastrectomy; it does suggest that postoperative inflammatory surveillance may deserve more attention in the sleeve population than in patients who undergo gastric bypass.
The findings also raise research questions that claims data cannot answer. There is no information here on serologic status, radiographic evolution, symptom severity, body composition change, smoking, family history, or the exact timing of symptom onset relative to weight trajectory. Without those details, the mechanism behind the association remains inferential rather than proven. Follow-up work will need to determine whether the excess early incidence reflects altered immune signaling, unmasking of preclinical disease, differential healthcare contact, or a combination of these factors.
For now, the most defensible interpretation is narrow and practical. In this French nationwide cohort, sleeve gastrectomy was followed by a higher early incidence of incident inflammatory arthritis than gastric bypass, while the difference disappeared after six years. The study adds another reason to monitor postoperative patients for new rheumatic symptoms, especially when the operation selected is sleeve gastrectomy and the first postoperative years are still unfolding.